The method of our time is to use not one but multiple exploration models.

Marshall McLuhan





Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia (Matsushita M et al, 2017)(pfd)

The team conducted various pharmacological tests for future clinical application in ACH. Pharmacokinetic analyses demonstrated that peak drug concentration (Cmax) and area under the concentration-time curve (AUC) of 2mg/kg of meclozine to mice was lower than that of 25mg/body to human, which is a clinical usage for anti-motion-sickness

Read full document here